Viking Therapeutics, Inc. (VKTX)

NASDAQ: VKTX · Real-Time Price · USD

32.94

+0.33 (1.01%)

At close: Aug 4, 2026, 4:00 PM EDT

33.45

+0.51 (1.55%)

Pre-market: Aug 5, 2026, 8:27 AM EDT

Viking Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-534.8	-359.64	-109.96	-85.9	-68.87	-54.99
Depreciation & Amortization	0.45	0.43	0.35	0.29	0.29	0.3
Stock-Based Compensation	37.39	40.82	29.71	16.75	8.67	6.1
Other Adjustments	-5.88	-9.27	-17.25	-8.07	1.32	3.94
Changes in Accounts Payable	63.52	43.44	2.3	-1.02	7.09	-2.54
Changes in Accrued Expenses	14.47	6.17	5.82	-1.82	5.81	-0.51
Changes in Other Operating Activities	6.43	-0.63	1.24	6.38	-2.71	0.12
Operating Cash Flow	-418.44	-278.69	-87.79	-73.38	-48.4	-47.59
Operating Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Purchases of Investments	-204.44	-418.04	-1,113	-478.3	-121.43	-168.02
Proceeds from Sale of Investments	565.23	759.43	560	299.22	176.18	205.98
Investing Cash Flow	399.26	341.39	-553.37	-179.09	54.75	37.96

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Issuance of Common Stock	111.25	76.44	654.57	278.5	12.49	7.59
Repurchase of Common Stock	-	-	-42.1	-7.12	-8.33	-0.71
Net Common Stock Issued (Repurchased)	111.25	76.44	612.46	271.38	4.16	6.88
Financing Cash Flow	111.25	76.44	612.46	271.38	4.16	6.88

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Foreign Exchange Rate Adjustments	0.02	-0.01	-0.15	-0.03	-0.26	-
Net Cash Flow	92.06	139.14	-28.69	18.91	10.52	-2.75

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-418.44	-278.69	-87.79	-73.38	-48.4	-47.59
Free Cash Flow Growth	-	-	-	-	-	-
Free Cash Flow Per Share	-3.65	-2.47	-0.81	-0.78	-0.63	-0.62
Levered Free Cash Flow	-449.93	-310.23	-100.26	-82.06	-58.39	-57.62
Unlevered Free Cash Flow	-475.15	-343.93	-141.21	-96.99	-59.88	-58.31

SEC Filings: 10-K · 10-Q